Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicine composition, medicine containing medicine composition for regulating uric acid content in blood and application thereof

A composition and drug technology, applied in the field of medicine, can solve the problems of poor curative effect, large toxic and side effects, etc., and achieve the effect of lowering blood pressure, low toxic and side effects, and dilating blood vessels

Inactive Publication Date: 2016-10-12
BEIJING KANGLIJI BIOLOGICAL TECH CO LTD
View PDF4 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] The main purpose of the present invention is to provide a pharmaceutical composition, a drug containing it for regulating uric acid concentration in blood and its application, so as to solve the problem of large toxic side effects or poor curative effect of existing uric acid regulating drugs

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicine composition, medicine containing medicine composition for regulating uric acid content in blood and application thereof
  • Medicine composition, medicine containing medicine composition for regulating uric acid content in blood and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0049] The composition of the pharmaceutical composition: 60g potassium citrate, 40g sodium citrate, 1.5g iron citrate, 130g calcium citrate, 0.5g manganese citrate, 4g magnesium citrate, 25g seaweed polysaccharide, 15g lutein, 35g cyanine Vegetables, 25g anisaldehyde and 100g fructan.

[0050] Preparation method: sieve the above-mentioned components, then accurately weigh each component with the required weight, mix and stir evenly, and make tablets.

Embodiment 2

[0052] The composition of the pharmaceutical composition: 72g potassium citrate, 72g sodium citrate, 3g iron citrate, 215g calcium citrate, 1.4g manganese citrate, 7g magnesium citrate, 14g seaweed polysaccharide, 7g lutein, 14g anthocyanin , 7g anisaldehyde, 86g fructan and 600g PEG 4000, 600g PEG 6000.

[0053] Preparation method: sieve the above components, then accurately weigh the required weight components, mix and stir evenly, add PEG4000 and PEG6000 to make drop pills and cool.

Embodiment 3

[0055] The composition of the pharmaceutical composition: 147g potassium citrate, 49g sodium citrate, 2g iron citrate, 148g calcium citrate, 1g manganese citrate, 15g magnesium citrate, 20g seaweed polysaccharide, 10g lutein, 30g anthocyanin, 20g anisaldehyde, 60g fructan, 4g simple syrup, 2g sodium benzoate, 2g sodium alginate, 1.5g xanthan gum, hydrochloric acid (adjust the pH of the solution to 4.0) and 3000g sterile water.

[0056] Preparation method: sieve the above-mentioned components, accurately weigh the required weight components; dissolve the weighed components in sterile water, and then add simple syrup, sodium benzoate, sodium alginate, and xanthan gum , hydrochloric acid is added dropwise to adjust the pH value of the solution to 4.0, and then sterilized and filled to prepare an oral liquid.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a medicine composition, a medicine containing the medicine composition for regulating the uric acid content in blood and application thereof. The medicine composition includes a main drug, wherein the main drug includes alkaline mineral salt and optimal natural herb extract, wherein the alkaline mineral salt is one or more of soluble potassium salt, soluble sodium salt, soluble ferric salt, soluble calcium salt, soluble manganese salt and soluble magnesium salt; the natural herb extract is one or more of algal polysaccharides, lutein, anthocyanin, anisaldehyde and fructan. According to the medicine composition, addition of the alkaline mineral salt is advantageous to improve the solubility of uric acid crystal precipitation and promote drainage of uric acid; the natural herb extract is a natural ingredient, has low toxic and side effects, and is beneficial to improvement of physiological functions of a human body; and the alkaline mineral salt and natural herb extract are combined and synthesized, so that the regulating effect of the medicine composition for regulating the uric acid in blood can be improved. Therefore, the medicine composition has low toxic and side effects, and has the advantage of effectively regulating the uric acid content in blood.

Description

technical field [0001] The invention relates to the field of medicine, in particular to a pharmaceutical composition, a medicine containing the medicine for regulating the concentration of uric acid in blood and its application. Background technique [0002] There are about 1,200 mg of uric acid in the human body, about 600 mg is newly generated every day, and 600 mg is excreted at the same time, which is in a balanced state. Because many people now have unscientific diet and irregular living habits, they are more prone to hyperuricemia. Among them, the elderly are the main group of hyperuricemia due to their weak body functions. Too much uric acid produced in the body is too late to be excreted or the uric acid excretion mechanism degrades, which will lead to excessive retention of uric acid in the body. When the concentration of uric acid in the blood is greater than 7 mg / dl, the acidity of the body fluids will affect the normal function of human cells. Cause gout. Patie...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/295A61K31/733A61P19/06A61K31/28A61K31/191A61K31/715A61K31/047A61K31/352A61K31/11
CPCA61K33/32A61K31/047A61K31/11A61K31/191A61K31/352A61K31/715A61K31/733A61K33/26A61K2300/00
Inventor 陈曼赵鑫佘佐彦
Owner BEIJING KANGLIJI BIOLOGICAL TECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com